The Edmonton Region has much to capitalize on in the life sciences. Learn how API is leading the way to bringing this industry to its full potential through game-changing projects like the Canadian Critical Drug Initiative which recently received $80.5M in federal funding.

API is a not-for-profit organization with an expert interdisciplinary team that works with a network of collaborating organizations. As a whole, we provide the expertise, services, and infrastructure of a pharmaceutical company. We help innovators launch their ideas into the real world, connect industry to the services they need for commercial success, and accelerate all aspects of the drug development process.

Throughout the past two decades Andrew has successfully led  partnerships between industry, academia, government, and donors, and developed catalysts for economic investment totalling more than $600 million. With a background in economics and public sector management, Andrew has worked with UBC, and the University of Alberta, most recently as Assistant Dean for the Faculty of Pharmacy and Pharmaceutical Sciences. 

If attending in person please register before 12 noon MST Thursday July 13th.